Nektar to cut over 500 jobs following cancer drug failure April 25, 2022 (Reuters) – Nektar Therapeutics said on Monday it would lay
Nektar stops clinical trials for key cancer drug, shares tumble April 14, 2022 (Reuters) – Nektar Therapeutics said on Thursday it had stopped all